In mammals, differences in sex-chromosome constitution between males (XY) and females (XX) have led to the evolution of dosagecompensation strategies, including transcriptional silencing of one X chromosome in females 1 . In mice, X-chromosome inactivation (XCI) first initiates in the preimplantation embryo. The noncoding RNA Xist is expressed only from the paternal allele, thus leading to paternal X-chromosome (Xp) inactivation 2 . The Xp remains inactive in extraembryonic tissues but is reactivated in the inner cell mass, and this reactivation is followed by random XCI in the embryo proper 3,4 . In early mouse embryos, XCI has been shown to be very dynamic, and its requirements, both in cis at the level of the X-inactivation center (Xic) and in trans, have been debated 5 . Imprinted XCI has been proposed to initiate de novo 2,6 after the onset of zygotic genome activation (ZGA) and Xist expression. One study has proposed that Xp inactivation is initially Xist independent and that Xist may be required only for early maintenance of silencing 7 , whereas another study has reported a lack of Xp gene silencing in the absence of Xist 8 . However, these studies were based on the analysis of just a few genes. Two recent single-cell transcriptomic studies have exploited interspecific crosses to investigate XCI in female preimplantation embryos 6 and differentiating embryonic stem cells (ESCs) 9 . These studies have revealed that imprinted XCI indeed initiates between the four-and eight-cell stages 6 and that progression of random XCI is correlated with differentiation 9 . However, the extent to which initiation of Xp-linked gene silencing is dependent on Xist RNA or is influenced by the strain or parent of origin (e.g., imprinted X-linked genes) has not been investigated.
a r t i c l e s
In mammals, differences in sex-chromosome constitution between males (XY) and females (XX) have led to the evolution of dosagecompensation strategies, including transcriptional silencing of one X chromosome in females 1 . In mice, X-chromosome inactivation (XCI) first initiates in the preimplantation embryo. The noncoding RNA Xist is expressed only from the paternal allele, thus leading to paternal X-chromosome (Xp) inactivation 2 . The Xp remains inactive in extraembryonic tissues but is reactivated in the inner cell mass, and this reactivation is followed by random XCI in the embryo proper 3, 4 . In early mouse embryos, XCI has been shown to be very dynamic, and its requirements, both in cis at the level of the X-inactivation center (Xic) and in trans, have been debated 5 . Imprinted XCI has been proposed to initiate de novo 2, 6 after the onset of zygotic genome activation (ZGA) and Xist expression. One study has proposed that Xp inactivation is initially Xist independent and that Xist may be required only for early maintenance of silencing 7 , whereas another study has reported a lack of Xp gene silencing in the absence of Xist 8 . However, these studies were based on the analysis of just a few genes. Two recent single-cell transcriptomic studies have exploited interspecific crosses to investigate XCI in female preimplantation embryos 6 and differentiating embryonic stem cells (ESCs) 9 . These studies have revealed that imprinted XCI indeed initiates between the four-and eight-cell stages 6 and that progression of random XCI is correlated with differentiation 9 . However, the extent to which initiation of Xp-linked gene silencing is dependent on Xist RNA or is influenced by the strain or parent of origin (e.g., imprinted X-linked genes) has not been investigated.
In this study, we set out to explore the precise kinetics of paternal and maternal X-linked gene expression during preimplantation embryogenesis, by using interspecific crosses and single-cell RNA sequencing (scRNA-seq). We investigated the differences in the dynamics of imprinted XCI that were attributable to genetic background and/or to parental origin. By investigating X-linked gene expression in female embryos derived from Xist-knockout (KO) males, we also demonstrated the absolute Xist dependence of early imprinted XCI and observed the genome-wide transcriptional consequences induced by a lack of dosage compensation. Overall, this study provides insight into the transcriptional and allelic dynamics of XCI as well as the nature of the requirement for dosage compensation during the first stages of mammalian development.
RESULTS

Allele-specific scRNA-seq during preimplantation development
To investigate the extent and requirements of gene silencing during imprinted XCI in early embryogenesis, we profiled the expression kinetics of genes on the Xp and Xm chromosomes, by using scRNAseq 10 . F 1 embryos were derived from interspecific crosses of either wild type (WT) or Xist paternally deleted mutant (Xist pat∆ ) origin, between the two-cell and blastocyst (approximately 60-to 64-cell) stages. Reciprocal crosses between highly polymorphic Mus musculus castaneus (Cast/EiJ) and Mus musculus domesticus (C57BL6/J) strains, herein referred to as Cast and B6, respectively, were used (Fig. 1a) , and a minimum of five embryos and six single cells per stage for WT embryos from B6 female × Cast male (BC) or Cast female × B6 male (CB) crosses (Supplementary Data Set 1). Of 24,499 referenced mouse genes, 15,581 were expressed in at least one developmental stage, including 580 X-linked genes.
We first assessed the extent to which transcriptomes of single cells were associated by stage, sex or cross, by performing principal component analysis (PCA) and hierarchical clustering ( Fig. 1b and  Supplementary Fig. 1 ). The primary source of variability among all cells was developmental stage, as expected on the basis of previous studies 6 , thus validating the quality of our data. Single-cell transcriptomes clustered to a lesser extent by cross (BC and CB) and then by sex (XX and XY) (Supplementary Fig. 1 ), and the differences between the sexes reached a minimum by the 32-cell and blastocyst stages, presumably because of dosage compensation.
Timing of dosage compensation and imprinted XCI
To assess the precise timing of dosage compensation in male and female embryos, we examined autosomal and X-linked transcripts at each stage in both sexes. According to Ohno's law 11 average X-linked gene expression should be equivalent to the expression of autosomal genes. Furthermore, equal expression of X-linked genes between females and males is expected through XCI. We compared X/autosome (X/A) expression ratios in single blastomeres of each sex (Fig. 1c) . The expected X/A ratios were 1 in females and 0.5 in males in the absence of any dosage compensation (i.e., no X overexpression compared with autosomes, and no XCI). We found that the X/A ratios were significantly higher than expected as early as the four-cell stage (P < 9 × 10 −4 for males and females after the four-cell stage, by two-sided t test) and continued to rise until the 32-cell stage, thus suggesting that there is a progressive increase in expression of the X chromosome compared with autosomes at the same time as, or soon after ZGA. In females, the X/A ratio rose to 1.58 by the 32-cell stage and then significantly dropped to 1.37 by the early blastocyst stage (P = 1.96 × 10 −2 between 32-cell and blastocyst stages, by KruskalWallis (KW) test), presumably because of XCI by this stage (described below). This finding suggests that X/A ratios in female blastocysts progressively reach 1, although even at the early blastocyst stage, the ratios were still slightly higher than those in males (P = 2.03 × 10 −3 by KW), in agreement with previously published data 12, 13 .
We next investigated allele-specific X-linked gene expression and the timing of XCI in BC and CB female embryos. At the two-cell stage, ZGA and massive degradation of the maternal pool of mRNAs occur. Transcripts were maternally biased genome wide, as expected given the residual maternal pool (Fig. 1d) . At subsequent stages, 14) (additional data in Supplementary Fig. 2 ). Mean percentages of parental-origin transcripts are represented between oocytes (oo) and blastocysts (blasto.). Source data for b-e are available online.
a r t i c l e s autosomal transcripts reached parity for both parental genomes, with a parental ratio in blastocysts of 0.5 in both crosses, whereas X-linked transcripts displayed maternal skewing even at the 16-cell stage. By the blastocyst stage, global transcription of the Xp was significantly decreased in both crosses (P < 2.2 × 10 −16 by KW), thus indicating that XCI was fairly complete, as previously reported 6, 8, 14 . We compared the kinetics of Xp silencing for 13 X-linked genes previously analyzed by fluorescence in situ hybridization targeting nascent RNA (RNA-FISH) 14 and found that most (12/13) genes showed very similar patterns ( Fig. 1e and Supplementary Fig. 2 ), thus giving us confidence that our scRNA-seq data, bioinformatics pipeline and expression thresholds were valid. The one gene (out of the 13) for which slightly earlier Xp silencing was found by scRNA-seq, as compared with results from previous reports, was Atrx. By using RNA-FISH with a gene-specific probe, we confirmed that Atrx was inactivated on the Xp in most cells by the morula stage (Supplementary Fig. 3a) .
We also confirmed its previously reported Xp reactivation in the blastocyst 14 ( Supplementary Fig. 2 ).
Strain-specific XCI and escape
We established an in vivo chromosome-wide map of X-linked gene activity between the four-cell and blastocyst stages. Of the 580 X-linked genes expressed in our scRNA-seq, we focused on the 164 (BC cross) and 134 (CB cross) most highly expressed and informative genes (i.e., those with reads per retrotranscribed length per million mapped reads (RPRT) >4 and expressed in at least 25% of the cells of each stage and cross, with a minimum of two cells), for which we were able to establish allelic expression profiles with confidence (125 common genes between BC and CB crosses in Supplementary Fig. 3b and Fig. 2 ; details of allelic expression thresholds in Online Methods). A striking switch from biallelic (gray, light pink or light blue) expression at the four-cell stage to monoallelic maternal (red) expression at the blastocyst stage was observed for most X-linked genes. Several genes underwent only partial or no XCI (termed escapees) and will be discussed later. As expected, Xist expression was exclusively of paternal origin throughout ( Fig. 2 Fig. 2 and Supplementary Fig. 3b ). By the blastocyst stage, Xp reached a very similar state of inactivation in both BC and CB crosses (83.5% and 84.3% of the 164 and 134 X-linked informative and expressed genes, respectively, were either silenced or maternally biased at the blastocyst stage; Figs. 2 and 3a,b). However, when comparing gene expression in embryos derived from BC and CB crosses (125 common genes), we observed marked differences between crosses, with just 71.2% (89 of 125 genes) of X-linked genes falling into the same or a similar category between BC and CB crosses (e.g., early and mid or late and biased). The degree of inconsistency in silencing kinetics between crosses was evaluated if more than one developmental stage separated the same gene between BC and CB crosses (Supplementary Table 1 and classification details in Online Methods). Several genes also showed strain-specific escape (Fig. 3b) . Some of these genes have previously a r t i c l e s been described 16 or reported to escape in a tissue-specific fashion at later stages of development or in somatic tissues (e.g., Ddx3x and Idh3g) [16] [17] [18] . However, several genes remained biallelically expressed even at the blastocyst stage and tended to show escape independently of strain ( Fig. 3b and Supplementary Table 2 inside (TSS located in an Xist entry site), next to (TSS located less than 100 kb from an entry site) and outside (over 100 kb from an entry site). *P < 0.05 by Dunn's test. Consistent or strain-specific genes were used. Box plots are as in Figure 1c . Source data are available online.
a Fig. 3b ) corresponded to genes that previously underwent Xp silencing before the blastocyst stage but then became reexpressed, as previously described for Atrx 14 .
Xist entry sites and early silenced genes
We next assessed whether the gene-silencing kinetics was correlated with the genomic position along the X chromosome. We first focused on the 71.2% (n = 89 genes) of genes with correlated kinetics between crosses and the strain-specific genes (n = 48). According to our allele-specific-expression heat map, although early and intermediatesilenced genes tended to lie closer than late-silenced genes to the Xic (Fig. 3c) , gene silencing did not appear to occur as a simple linear gradient from the Xic, with some escapees close to the Xic (Fig. 2) . Instead, we noted that several regions across the X chromosome contained early silenced genes (e.g., Pnma5, Kif4 and Magt1), from which silencing appeared to 'spread' locally (Fig. 2) . A recent study in ESCs has shown that Xist RNA initially binds to specific genomic regions (Xist entry sites) along the X chromosome, in a manner dependent on 3D proximity to the Xist locus 20 . This binding has been hypothesized by Engreitz et al. to silence genes locally and to then spread along the rest of the X chromosome 20 . We found that X-linked genes located within the predicted Xist entry regions (8 and 11 genes, respectively, in 32-cell embryos and blastocysts) or close to these regions (20 and 23, respectively, in 32-cell embryos and blastocysts) showed the earliest silencing and the strongest maternal imbalance (P = 0.02 and P = 0.03, respectively, by KW, in 32-cell embryos and blastocysts; Fig. 3d) . Thus, the Xist-RNA entry sites, as defined in ESCs 20 may potentially correspond to XCI-initiation sites in vivo during imprinted XCI.
Fully Xist-dependent imprinted XCI The above findings suggested that Xist RNA plays an early role in triggering gene silencing during imprinted XCI. This finding contrasts with results from a previous report suggesting that initiation of imprinted XCI is Xist independent 7 . Indeed, although Xist pat∆ females die around embryonic day (E)10.5 and exhibit marked growth delays 21 , mutant and WT females appeared morphologically indistinguishable during preimplantation development (data not shown). To evaluate whether XCI could be established, even in the absence of Xist expression, as previously reported 7 , we examined X-linked gene expression profiles in single cells of preimplantation female embryos carrying a paternal Xist deletion (Xist pat∆ ) 21, 22 . Xist is normally expressed exclusively from the Xp in preimplantation embryos 2 (Fig. 2) . Transcriptomes of single blastomeres from hybrid F 1 embryos (Cast females crossed with B6 males carrying a maternal Xist deletion (Xist mat∆ )) were compared with CB WT embryos from the eight-cell stage (when XCI normally initiates for some genes) to the blastocyst stage. We found similar X/A expression ratios between mutant and control female embryos up to the 32-cell stage (Fig. 4a) . However, at the blastocyst stage, the X/A ratios remained much higher in mutants than in WT embryos, whereas this ratio normally decreases because of XCI (P = 1.77 × 10 −4 by KW). This result indicated that Xp silencing was not initiated in Xist pat∆ female blastocysts. Bioinformatics analysis on the Xist-mutant single-cell transcriptomes was used to produce an allele-specific expression heat map (Online Methods), and, as expected given the absence of apparent dosage compensation in the mutants, we found that X-linked genes remained significantly biallelically expressed in Xist pat∆ embryos (Fig. 4b) . Only two genes (Rgn and Tktl1) out of 122 assessed (i.e., 1.6%) showed maternal monoallelic expression in Xist pat∆ mutant blastocysts, compared with 84.3% in CB WT controls. One of these genes, Tktl1, has been hypothesized to be imprinted 23 . Moreover, Fthl17f, a well-known imprinted gene, was aberrantly expressed in Xist pat∆ blastocysts, thus suggesting a lack of Xp silencing. We therefore found no evidence of Xist-independent XCI (Supplementary Fig. 5a ), even for X-linked genes previously proposed by Kalantry et Fig. 5a , left). However this result was probably due to variability in parentalorigin expression, as also observed in CB controls (Abcb7 and Fmr1, Supplementary Figs. 3, 4 and 5a) rather than to Xp silencing. Instead, our data are in agreement with those from a study by Namekawa et al. 8 , in which Xist-dependent Xp silencing has been proposed to occur on the basis of nascent RNA-FISH on two-cell-stage to blastocyst-stage embryos and allele-specific RT-PCR on morulae, although that study was based on 14 genes, 10 of which were in common with those in ref. 5 . The discrepancies between these previous studies are probably due to technical differences. The scRNA-seq analysis in the present study provides chromosome-wide evidence of Xist-dependent gene silencing during preimplantation embryogenesis and corroborates recent findings of Xist-dependent X-linked gene dosage 13 .
Improper gene expression in Xist-mutant embryos
The transcriptome of Xist pat∆ embryos provided us with a unique opportunity to explore the molecular defects that occur in the absence of paternal XCI. A genome-wide analysis of differentially expressed (DE) genes was performed in WT and Xist pat∆ embryos (Supplementary Data Set 2) . Expression profiles of single blastomeres of controls and mutants still clustered according to developmental Figure 4 Paternal knockout of Xist impairs XCI, dosage compensation and differentiation pathways. (a) Differences in ratios of X-chromosome expression levels to autosomal expression levels, from eight-cell to blastocyst stages in CB females (left) and Xist pat∆ CB females (with a paternally inherited knockout allele) (right). Box plots are as in Figure 1c . Numbers of cells analyzed per stage are given in Supplementary Data Set 1. (b) Heat map representing allele-specific mean expression from eight-cell to blastocyst stages of X-linked genes (as in Fig. 2) in Xist pat∆ -mutant single cells. Red, strictly maternally expressed genes (allelic ratio ≤0.15); blue, strictly paternally expressed genes (allelic ratio ≥0.85). Color gradients are used in between, and genes are ordered on the basis of genomic position. Tsix was included in the heat map if it was expressed in at least two single cells per stage, even though it did not reach the expression threshold used (RPRT >4 and expressed in at least 25% of the cells of each stage and cross, with a minimum of two cells). n = 122 genes. Rhox5 is not included, because of a lack of SNPs. a r t i c l e s stage by PCA (data not shown). However, at the 8-cell and 32-cell stages, a markedly elevated number of DE autosomal genes (false discovery rate <0.05) was found in Xist pat∆ embryos compared with WT (Supplementary Fig. 5b) . By the blastocyst stage, when paternal XCI is normally complete in WT females, 30% of the total upregulated genes in Xist pat∆ embryos were found to be X-linked, thus corroborating an XCI defect in the absence of Xist. DE genes included Tsix (encoding the antisense transcript to Xist) which is normally not expressed from the Xp at the 32-to 64-cell stages 24 (Fig. 4b,d and Supplementary Fig. 5b ). The absence of Xist on the paternal X chromosome thus releases paternal Tsix repression in cis (without affecting the maternally imprinted Xist/Tsix alleles). 30 . The human RHOXF1 gene, which has been hypothesized to be related to mouse Rhox5 (ref. 31) shows similar sexspecific and lineage-specific expression in human preimplantation embryos 32 . Importantly, previous in vitro studies have demonstrated that overexpression of Rhox5 blocks differentiation of ESCs by preventing exit from pluripotency 33, 34 . We validated Rhox5 upregulation at the protein level by using immunofluorescence and found that Xist pat∆ female blastocysts, compared with WT blastocysts, showed significantly higher Rhox5 staining, particularly in the polar trophectoderm and inner-cell-mass region of the embryo (Fig. 5b,d,f,g ). Quantification of Rhox5 immunofluorescence showed a significant increase in Rhox5 protein levels (P = 0.0171 by Kolmogorov-Smirnov (KS) test; Fig. 5h ) and in the number of cells stained by anti-Rhox5 (Fig. 5f ). This result correlated well with our scRNA-seq data. We conclude that even by the early blastocyst stage, the lack of initiation of Xp inactivation in Xist pat∆ embryos leads to inappropriate downregulation of several key genes involved in extraembryonic development, overexpression of several pluripotency genes and massive overexpression of Rhox5, all of which may interfere with appropriate subsequent differentiation.
DISCUSSION
Here we demonstrated the key role of Xist RNA in initiating imprinted XCI. Although its role in triggering random XCI has previously been established, our study provides evidence that Xist is also essential for initiating early paternal XCI. Furthermore, our scRNA-seq analysis enabled us to identify the molecular defects in developmental pathways that emerge from this absence of dosage compensation and result in lethality several days later. Absence of Xist leads to an inappropriate downregulation of extraembryonic-development genes, a lack of downregulation of some pluripotency genes and massive overexpression of Rhox5. Together, some or all of these defects must ultimately result in compromised extraembryonic development and redirection toward what appears to be a more pluripotent state, or at We explored the degree to which transcriptomes were perturbed in the Xist-mutant embryos by using Ingenuity Pathway Analysis software. We found that many aberrantly downregulated genes in Xist pat∆ female blastocysts were associated with extraembryonictissue pathways, embryonic growth and cell viability (Fig. 4c and  Supplementary Data Set 3 (Fig. 4d) . To confirm the aberrant decrease in Sox17-positive cells in the PrE in Xist pat∆ females, we performed immunofluorescence analysis on late blastocysts (Fig. 5a,c,e,g ). In Xist pat∆ females, compared with their male littermates, fewer cells expressed Sox17, and the intensity of fluorescence of Sox17 was slightly decreased (Fig. 5g) , thus corroborating the decrease in mRNA expression that we observed by scRNA-seq.
Importantly, in addition to aberrant downregulation or repression of extraembryonic genes, we also found abnormal overexpression of several pluripotency genes including Prdm14, Esrrb and Tcl1 in Xist pat∆ embryos. This result suggested an inappropriate activation or lack of repression of such factors in the absence of XCI (Fig. 4d) and was relevant to our recent findings showing that the presence of two active X chromosomes delays exit from pluripotency in ESCs by preventing downregulation of key genes, such as Prdm14 and Esrrb 22 . Moreover, aberrant overexpression of Prdm14, Esrrb and Tcl1 has been observed in Xist −/− female ESCs induced to differentiate 22 . Intriguingly, the most significantly upregulated gene (log fold change of 10) in Xist pat∆ female blastocysts was the imprinted Rhox5 gene, also known as Pem-1 ( Fig. 4d and legend to Fig. 4b ). Rhox5 is a member of the reproductive X-linked Hox (Rhox) cluster and is expressed exclusively in the male germ line and in female (but not male) preimplantation embryos (Xp only) 30 . After implantation, its expression switches to the maternal allele and becomes restricted to a r t i c l e s least a state from which further differentiation is perturbed. Previous studies 22 and a recent scRNA analysis of differentiating ESCs 9 have found that XCI progression is negatively correlated with pluripotency and positively correlated with differentiation. The gene expression perturbations that we observed in Xist-mutant embryos and their subsequent lethality are consistent with these previous observations and implicate some of the factors that are potentially involved. It is also notable that the previously reported 33 aberrant induction of maternal Xist and Xm inactivation in extraembryonic tissues of blastocysts carrying a maternal Tsix deletion indicates that the presence of two active X chromosomes at the blastocyst stage can still be rescued in some females and suggests that the major defect associated with a lack of paternal XCI is initially in the extraembryonic lineage.
In this study, we also defined the influence of chromosomal location, as well as genetic background and parent of origin, on XCI kinetics. Our finding that Xist's predicted initial binding sites on the X chromosome correspond to the earliest regions silenced, between the 8-and 16-cell stages, with evidence for local spreading in cis at the 32-cell blastocyst stage, should enable exploration of the local features that underlie the spread of silencing along the X chromosome in an in vivo context. Finally, our study demonstrated the critical requirement for accurate X-chromosome gene dosage during early embryonic development and uncovered some of the key pathways and factors that are affected in the absence of XCI. Future dissection of these pathways and their relationship to X-linked gene dosage should provide a better understanding of the important roles of even small changes in RNA and protein levels, not only in development but also in disease.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. expressed genes were only partially covered (less than 50% of the gene size in average). To estimate transcript abundance, read counts were thus normalized on the basis of the amplification size of each transcript (RPRT) rather than on the basis of the size of each gene (RPKM).
Filtering of biased SNPs. Because we observed a bias for some polymorphisms when we should not have (e.g., in oocytes with only maternal expression or male cells with only maternal expression for the X chromosome), we decided to remove biased SNPs from our study. Oocytes and male cells were used to address this issue. Therefore, SNPs covered by at least five reads and having an allelic ratio greater than 0.3 (biallelic or paternally expressed) in at least two of these samples were discarded. In total, 275 SNPs were filtered out, including 40 sites located on the X chromosome.
Generation of Xist pat∆ -mutant embryos involved the use of an Xist ∆/Y sire of mixed background (mixed background: B6D2F1(C57BL/6J;DBA/2J);129S1/ SvlmJ;BALB/cJ.). We therefore had to apply another SNP filtration to the KO samples to remove all B6 polymorphisms that might have been lost on the X chromosome because of the mixed background of the Xist ∆/Y sire. To this end, all existing SNPs between B6 and DBA/2J, 129S1/SvlmJ and BALB/cJ on the X chromosome were removed from our SNP database (34,397 SNPs, representing 5.5% of X-chromosome SNPs between B6 and Cast).
Principal component analysis, hierarchical clustering and differentially expressed genes. Count tables of gene expression were generated with the refSeq annotation and HTSeq software (v0.6.1) 41 . Only genes with an RPRT value >1 in at least 25% of the single cells of at least one developmental stage (with a minimum of two cells) were kept for the downstream analysis. The TMM method from the edgeR R package (v3.14.0) 42 was first used to normalize the raw count data. PCA and hierarchical clustering were then used to determine how single cells were clustered to the others, on the basis of their gene expression profiles, depending on their stage, sex and cross. PCA on normalized data was performed with the FactoMineR R package (v1.33). Hierarchical clustering analysis was based on Spearman correlation distance and the Ward method, with the hclust function implemented in the gplots R package (v3.0.1). The limma R package (v3.28.4) 43 was applied to identify the differentially expressed genes between the eight-cell and blastocyst stages in control and Xist pat∆ -mutant females. With the Benjamini-Hochberg correction, genes with an adjusted P value lower than α = 0.05 were called as differentially expressed.
Functional enrichment analysis. Downregulated genes in Xist pat∆ -mutant female blastocysts compared with CB female blastocysts were analyzed with Qiagen's Ingenuity Pathway Analysis (IPA, http://www.qiagen.com/ingenuity). The Functions and Diseases module was used to extract the most significantly deregulated pathways and their associated genes.
Heat-map generation for X-chromosome allelic gene expression. For BC and CB heat maps, data from informative genes were analyzed at each developmental stage only if the gene was expressed (RPRT >4) in at least 25% of single blastomeres (with a minimum of two cells) at this particular stage and cross (Figs. 2 and 4b and Supplementary Fig. 3) . To follow the kinetics of expression, we decided to focus only on genes expressed in at least three different stages between the four-cell to blastocyst stages. The mean of the allelic ratio of each gene was represented for the different stages. The same gene candidate list was used to produce the Xist pat∆ heat maps (Fig. 4b) . A value was given only if the gene reached the threshold of RPRT >4 in at least 25% of single cells (with a minimum of two cells) per stage and cross.
Definition of X-linked gene silencing/escape classes. We automatically assigned X-linked genes that become strictly maternal (allelic ratio ≤0.15) at the 16-cell stage or earlier to the 'early silenced' gene class, assigned those that become maternal at the 32-cell stage to the 'intermediate silenced' class (allelic ratio NA or >0.15 at the 16-cell stage and ≤0.15 at the 32-cell stage), and assigned those silenced only by the blastocyst stage to the 'late silenced' gene class (allelic ratio NA or >0.15 at the 16-cell and 32-cell stages and ≤0.15 at the blastocyst stage). At the blastocyst stage, X-linked genes showing a maternal bias of expression (0.15 < allelic ratio ≤ 0.3) were categorized as maternally biased. A final group comprised genes that escaped imprinted Xp inactivation (allelic ratio >0.3 at the blastocyst stage) (Fig. 3a) . Genes escaping XCI were separated into two classes: 'constitutive escapees' if they were classified as escapees in both CB and BC stages and 'strain-specific escapees' if they were escapees in only one cross (Fig. 3b and  Supplementary Table 2) .
Existence of consistency in silencing kinetics between crosses was evaluated if no more than one developmental stage separated the same gene between BC and CB crosses. If the consistent genes belonged to two different classes, a class for all (BC + CB) was assigned, owing to their parental ratio mean of (BC mean + CB mean) in Figure 3a ,d. Dosage compensation and X/A expression ratio. We measured the global X/A expression ratio in females (XX/AA ratio) and males (X/AA ratio) as the level of expression of X-linked genes divided by the global level of expression of the autosomal genes. Only genes with an expression value RPRT >4 were used for subsequent analysis (Figs. 1d and 4a) . Adjustment of the number of expressed genes between the X chromosome and autosomes has been reported to be critical in X/A expression ratio measurement 44 . We then added a bootstrapping step and randomly selected, for each sample, an autosomal gene set with the same number of expressed genes compared with the X chromosome to estimate the global X/A ratio. This step was repeated 1,000 times, and the X/A expression ratio was estimated as the median of the 1,000 values. Data availability. The Gene Expression Omnibus accession number for the data sets reported in this paper is GSE80810. Source data for Figure 1 (Fig. 1b-e) , Figure 3 (3a-d) and Figure 4 (4a,d) are available with the paper online. All other data are available from the corresponding author upon reasonable request.
